Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Innovations and Challenges of Training in Geriatric Mental Health.

Lee EE, Balasubramaniam M, Joo JH, Manning K, Pontone GM, Kirkham J.

Am J Geriatr Psychiatry. 2019 Jul;27(7):655-659. doi: 10.1016/j.jagp.2019.04.017. Epub 2019 May 6. No abstract available.

PMID:
31122754
2.

An association between bipolar disorder and Parkinson disease: When mood makes you move.

Pontone GM, Koch G.

Neurology. 2019 Jun 11;92(24):1125-1126. doi: 10.1212/WNL.0000000000007641. Epub 2019 May 22. No abstract available.

PMID:
31118246
3.

Social role functioning in Parkinson's disease: A mixed-methods systematic review.

Perepezko K, Hinkle JT, Shepard MD, Fischer N, Broen MPG, Leentjens AFG, Gallo JJ, Pontone GM.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1128-1138. doi: 10.1002/gps.5137. Epub 2019 May 20. Review.

PMID:
31069845
4.

Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.

Smith GS, Mills KA, Pontone GM, Anderson WS, Perepezko KM, Brasic J, Zhou Y, Brandt J, Butson CR, Holt DP, Mathews WB, Dannals RF, Wong DF, Mari Z.

Parkinsonism Relat Disord. 2019 Apr 16. pii: S1353-8020(19)30201-9. doi: 10.1016/j.parkreldis.2019.04.006. [Epub ahead of print]

PMID:
31053531
5.

Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease.

Pontone GM, Dissanayaka N, Dobkin RD, Mari L, Marsh L, Vernaleo BA, Weintraub D, Mari Z.

Am J Geriatr Psychiatry. 2019 Jul;27(7):712-719. doi: 10.1016/j.jagp.2019.03.005. Epub 2019 Mar 13.

PMID:
30955991
6.

Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.

Hinkle JT, Perepezko K, Mills KA, Mari Z, Butala A, Dawson TM, Pantelyat A, Rosenthal LS, Pontone GM.

Parkinsonism Relat Disord. 2018 Oct;55:8-14. doi: 10.1016/j.parkreldis.2018.08.010. Epub 2018 Aug 22.

PMID:
30146185
7.

Absence of Evidence Versus Evidence of Absence-SAPS-PD.

Butala AA, Pontone GM.

Am J Geriatr Psychiatry. 2018 Oct;26(10):1012-1013. doi: 10.1016/j.jagp.2018.06.009. Epub 2018 Jul 7. No abstract available.

PMID:
30077588
8.

Onset and Remission of Psychosis in Parkinson's Disease: Pharmacologic and Motoric Markers.

Hinkle JT, Perepezko K, Bakker CC, Broen MPG, Chin K, Dawson TM, Johnson V, Mari Z, Marvel CL, Mills KA, Pantelyat A, Pletnikova O, Rosenthal LS, Shepard MD, Stevens DA, Troncoso JC, Wang J, Pontone GM.

Mov Disord Clin Pract. 2018 Jan-Feb;5(1):31-38. doi: 10.1002/mdc3.12550. Epub 2017 Sep 15.

9.

Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.

Hinkle JT, Perepezko K, Rosenthal LS, Mills KA, Pantelyat A, Mari Z, Butala A, Moukheiber E, Dawson TM, Pontone GM.

Parkinsonism Relat Disord. 2018 Aug;53:108-109. doi: 10.1016/j.parkreldis.2018.04.027. Epub 2018 May 2. No abstract available.

PMID:
29753604
10.

Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.

Hinkle JT, Perepezko K, Mari Z, Marsh L, Pontone GM.

Am J Geriatr Psychiatry. 2018 Jun;26(6):700-710. doi: 10.1016/j.jagp.2018.01.005. Epub 2018 Jan 31.

11.

Clinical Markers of Anxiety Subtypes in Parkinson Disease.

Broen MPG, Leentjens AFG, Hinkle JT, Moonen AJH, Kuijf ML, Fischer NM, Perepezko K, Bakker A, Pontone GM.

J Geriatr Psychiatry Neurol. 2018 Mar;31(2):55-62. doi: 10.1177/0891988718757369. Epub 2018 Mar 11.

12.

Psychosis in Neurodegeneration: Relating Phenomenology to Pathology and Prognosis.

Hinkle JT, Pontone GM.

Am J Geriatr Psychiatry. 2018 Mar;26(3):314-315. doi: 10.1016/j.jagp.2017.11.008. Epub 2017 Dec 26. No abstract available.

PMID:
29398353
13.

Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.

Mills KA, Greene MC, Dezube R, Goodson C, Karmarkar T, Pontone GM.

Int J Geriatr Psychiatry. 2018 Apr;33(4):642-651. doi: 10.1002/gps.4834. Epub 2017 Dec 13.

14.

Molecular imaging in neuropsychiatry.

Pontone GM, Mills KA, Smith GS.

Int Rev Psychiatry. 2017 Dec;29(6):527-529. doi: 10.1080/09540261.2017.1403201. Epub 2017 Dec 12. No abstract available.

PMID:
29231768
15.

Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.

Hinkle JT, Perepezko K, Rosenthal LS, Mills KA, Pantelyat A, Mari Z, Tochen L, Bang JY, Gudavalli M, Yoritomo N, Butala A, Bakker CC, Johnson V, Moukheiber E, Dawson TM, Pontone GM.

Parkinsonism Relat Disord. 2018 Feb;47:50-56. doi: 10.1016/j.parkreldis.2017.11.338. Epub 2017 Nov 21.

16.

Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.

Rutten S, van der Ven PM, Weintraub D, Pontone GM, Leentjens AFG, Berendse HW, van der Werf YD, van den Heuvel OA.

Parkinsonism Relat Disord. 2017 Oct;43:49-55. doi: 10.1016/j.parkreldis.2017.06.024. Epub 2017 Jul 5.

17.

Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.

Hinkle JT, Perepezko K, Bakker CC, Dawson TM, Johnson V, Mari Z, Marvel CL, Mills KA, Pantelyat A, Pletnikova O, Rosenthal LS, Shepard MD, Stevens DA, Troncoso JC, Wang J, Pontone GM.

Int J Geriatr Psychiatry. 2018 Jan;33(1):e131-e139. doi: 10.1002/gps.4736. Epub 2017 May 16.

18.

Visual Hallucinations in Neurodegenerative Diseases: Focus on Selective Tissue Vulnerability.

Hinkle JT, Pontone GM.

Am J Geriatr Psychiatry. 2017 Jun;25(6):605-606. doi: 10.1016/j.jagp.2017.02.011. Epub 2017 Feb 14. No abstract available.

PMID:
28285770
19.

Anxiety in Parkinson's: a complex syndrome of non-dopaminergic and dopaminergic etiology.

Pontone GM.

Eur J Neurol. 2017 Apr;24(4):541-542. doi: 10.1111/ene.13242. Epub 2017 Feb 8. No abstract available.

PMID:
28177179
20.

Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Taylor J, Anderson WS, Brandt J, Mari Z, Pontone GM.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1171-1180. doi: 10.1016/j.jagp.2016.08.017. Epub 2016 Sep 3.

21.

Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.

Mills KA, Mari Z, Pontone GM, Pantelyat A, Zhang A, Yoritomo N, Powers E, Brandt J, Dawson TM, Rosenthal LS.

Parkinsonism Relat Disord. 2016 Dec;33:107-114. doi: 10.1016/j.parkreldis.2016.09.025. Epub 2016 Sep 27.

22.

Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.

Mills KA, Mari Z, Bakker C, Johnson V, Pontone GM, Pantelyat A, Troncoso JC, Pletnikova O, Dawson TM, Rosenthal LS.

Parkinsonism Relat Disord. 2016 Dec;33:102-106. doi: 10.1016/j.parkreldis.2016.09.024. Epub 2016 Sep 25.

23.

Changes in Verbal Fluency in Parkinson's Disease.

Rosenthal LS, Salnikova YA, Pontone GM, Pantelyat A, Mills KA, Dorsey ER, Wang J, Wu SS, Mari Z.

Mov Disord Clin Pract. 2016 Oct 1;4(1):84-89. doi: 10.1002/mdc3.12421. eCollection 2017 Jan-Feb.

24.

Personality and reported quality of life in Parkinson's disease.

Pontone GM, Mari Z, Perepezko K, Weiss HD, Bassett SS.

Int J Geriatr Psychiatry. 2017 Mar;32(3):324-330. doi: 10.1002/gps.4475. Epub 2016 Apr 5.

25.

Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Wills AM, PĂ©rez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J; NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.

JAMA Neurol. 2016 Mar;73(3):321-8. doi: 10.1001/jamaneurol.2015.4265.

26.

The longitudinal impact of depression on disability in Parkinson disease.

Pontone GM, Bakker CC, Chen S, Mari Z, Marsh L, Rabins PV, Williams JR, Bassett SS.

Int J Geriatr Psychiatry. 2016 May;31(5):458-65. doi: 10.1002/gps.4350. Epub 2015 Aug 18.

27.

Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.

Qureshi AA, Cheng JJ, Sunshine AN, Wu A, Pontone GM, Cascella N, Lenz FA, Grill SE, Anderson WS.

Neurosurg Focus. 2015 Jun;38(6):E5. doi: 10.3171/2015.3.FOCUS1523.

PMID:
26030705
28.

Is the Parkinson Anxiety Scale comparable across raters?

Forjaz MJ, Ayala A, Martinez-Martin P, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Leentjens AF.

Mov Disord. 2015 Apr;30(4):545-51. doi: 10.1002/mds.26111. Epub 2014 Dec 27.

PMID:
25546697
29.

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Hirao K, Pontone GM, Smith GS.

Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Epub 2014 Nov 20. Review.

30.

Dopamine receptor agonist drugs and impulse control disorders.

Weiss HD, Pontone GM.

JAMA Intern Med. 2014 Dec;174(12):1935-7. doi: 10.1001/jamainternmed.2014.4097. No abstract available.

PMID:
25329734
31.

REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.

Mahajan A, Rosenthal LS, Gamaldo C, Salas RE, Pontone GM, McCoy A, Umeh C, Mari Z.

Tremor Other Hyperkinet Mov (N Y). 2014 Jun 23;4:245. doi: 10.7916/D84B2ZDF. eCollection 2014.

32.

Neuropsychiatric disorders and potentially preventable hospitalizations in a prospective cohort study of older Americans.

Davydow DS, Zivin K, Katon WJ, Pontone GM, Chwastiak L, Langa KM, Iwashyna TJ.

J Gen Intern Med. 2014 Oct;29(10):1362-71. doi: 10.1007/s11606-014-2916-8.

33.

The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.

Leentjens AF, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Martinez-Martin P.

Mov Disord. 2014 Jul;29(8):1035-43. doi: 10.1002/mds.25919. Epub 2014 May 23.

34.

Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Sagna A, Gallo JJ, Pontone GM.

Parkinsonism Relat Disord. 2014 Jul;20(7):708-15. doi: 10.1016/j.parkreldis.2014.03.020. Epub 2014 Apr 1. Review.

35.

Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.

Calleo J, Williams JR, Amspoker AB, Swearingen L, Hirsch ES, Anderson K, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone GM, Weiss H, Rabins P, Marsh L.

J Parkinsons Dis. 2013;3(4):603-8. doi: 10.3233/JPD-130264.

PMID:
24275604
36.

Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach.

Starkstein SE, Dragovic M, Dujardin K, Marsh L, Martinez-Martin P, Pontone GM, Richard IH, Weintraub D, Leentjens AF.

Am J Geriatr Psychiatry. 2014 Dec;22(12):1410-7. doi: 10.1016/j.jagp.2013.09.006. Epub 2013 Nov 5.

PMID:
24200594
37.

Dopamine transporter imaging in psychogenic parkinsonism and neurodegenerative parkinsonism with psychogenic overlay: a report of three cases.

Umeh CC, Szabo Z, Pontone GM, Mari Z.

Tremor Other Hyperkinet Mov (N Y). 2013 Sep 10;3. pii: tre-03-188-4324-2. doi: 10.7916/D8FB51PS. eCollection 2013.

38.

Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis.

Martinez-Martin P, Rojo-Abuin JM, Dujardin K, Pontone GM, Weintraub D, Forjaz MJ, Starkstein S, Leentjens AF.

Eur J Neurol. 2013 Aug;20(8):1198-203. doi: 10.1111/ene.12160. Epub 2013 Apr 14.

PMID:
23581431
39.

Pharmacologic treatment of anxiety disorders in Parkinson disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L.

Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29.

40.

Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale.

Pontone GM, Palanci J, Williams JR, Bassett SS.

Int J Geriatr Psychiatry. 2013 Apr;28(4):364-71. doi: 10.1002/gps.3833. Epub 2012 May 24.

41.

Familial aggregation of panic disturbances in Parkinson's disease.

Pontone GM, Palanci J, Bienvenu OJ, Liang KY, Nestadt G, Rabins PV, Williams JR, Marsh L.

J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):417-24. doi: 10.1176/jnp.23.4.jnp417.

42.

Gaps in treatment for anxiety in Parkinson disease.

Palanci J, Marsh L, Pontone GM.

Am J Geriatr Psychiatry. 2011 Oct;19(10):907-8. doi: 10.1097/JGP.0b013e318227fa37. No abstract available.

PMID:
21795961
43.

Anxiety and self-perceived health status in Parkinson's disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L.

Parkinsonism Relat Disord. 2011 May;17(4):249-54. doi: 10.1016/j.parkreldis.2011.01.005. Epub 2011 Feb 2.

44.

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L.

Mov Disord. 2009 Jul 15;24(9):1333-8. doi: 10.1002/mds.22611.

Supplemental Content

Loading ...
Support Center